Recombinant Taq DNA polymerase
Journal of Biotechnology · 2026-07 · 415 · 152-169
DOI: 10.1016/j.jbiotec.2026.04.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Biotechnology, 2026-07. Verfasst von Klaudia Žigová und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biotechnology, Faculty of Chemical and Food Technology, Slovak University of Technology, Radlinského 9, Bratislava 812 37, Slovakia. Hauptthemen laut MEDLINE: Taq Polymerase, Recombinant Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 174 Literaturangaben. Gefördert von: European Regional Development Fund, NextGenerationEU.
Abstract (Originalsprache)
The sudden COVID-19 pandemic highlights the importance of diagnostic assays in health security readiness. One persistent difficulty is the rapid molecular detection of pathogenic microorganisms and viruses. Taq DNA polymerase remains an essential component for COVID-19 molecular detection. Taq DNA polymerase exhibits a high level of thermostability, which results from tighter hydrophobic packing, increased salt bridges, shortened loops, and proline substitutions that reduce flexibility, enabling activity above 90 °C. In addition, engineered variants address limitations by improving fidelity, processivity, and stability. The enzyme´s thermostability has significantly increased the efficiency, automation, and specificity of PCR. Hot-start modifications using antibodies, aptamers, or chemical inhibitors further reduce non-specific amplification, strengthening its role in sensitive diagnostics. Although Taq polymerase is available from several commercial sources, it is crucial and urgent to produce enzymes recombinantly for use in research and diagnostic procedures. To satisfy the demands of industry, it is necessary to maximize and optimize its production. We provide an overview of the recombinant Taq DNA polymerase´s characteristics, structural features, engineering advances, production background and strategies, and purification history in this paper. Together, these insights underscore its central role in diagnostics, research, and biotechnology, as well as its continued relevance as a model enzyme for protein engineering.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biotechnology, Faculty of Chemical and Food Technology, Slovak University of Technology, Radlinského 9, Bratislava 812 37, Slovakia.
- Biomolecular Engineering Lab, Dipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, 6 12 Piazza Leonardo da Vinci 32, Milano 20133, Italy.
- Institute of Biotechnology, Faculty of Chemical and Food Technology, Slovak University of Technology, Radlinského 9, Bratislava 812 37, Slovakia. Electronic address: martin.rebros@stuba.sk.
Förderung
- European Regional Development Fund
- NextGenerationEU
Zitieren
APA
Žigová, K., Marčeková, Z., Gautieri, A., & Rebroš, M. (2026). Recombinant Taq DNA polymerase. Journal of Biotechnology, 415, 152-169. https://doi.org/10.1016/j.jbiotec.2026.04.002
Vancouver
Žigová K, Marčeková Z, Gautieri A, Rebroš M. Recombinant Taq DNA polymerase. Journal of Biotechnology. 2026;415:152-169. doi:10.1016/j.jbiotec.2026.04.002
BibTeX
@article{igov2026,
author = {Žigová, Klaudia and Marčeková, Zuzana and Gautieri, Alfonso and Rebroš, Martin},
title = {Recombinant Taq DNA polymerase},
journal = {Journal of Biotechnology},
year = {2026},
volume = {415},
pages = {152--169},
doi = {10.1016/j.jbiotec.2026.04.002}
}
EUVIMED